Evolocumab limits adverse cardiovascular outcomes among PCI patients
My patients ask about outcome data with PCSK9 inhibitors, is it worth it? Good to see more.
My patients ask about outcome data with PCSK9 inhibitors, is it worth it? Good to see more.
Ruchika Talwar hosts Yash Shah and Mihir Shah, a urologist from Jefferson in Philadelphia. They delve into their innovative research on the Utility of Artificial…
How are pediatric respiratory health outcomes affected by airway obstruction with a low FEV1 (classic obstruction) vs normal FEV1 (dysanaptic obstruction)?
Despite being absolutely clear that she wanted a quick, painless end of life, a geriatrician’s elderly mother receives aggressive care. How can we ensure that…
Blog highlights a landmark addition to AHRQ’s inventory of digital healthcare resources: Implementing the Digital Healthcare Equity Framework: A Practical Guide.
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: AHRQ and PCORI Learning Health System Embedded Scientist Training and Research Centers…
BRIDGEPORT, Conn. (WTNH) – Connecticut’s Morning Buzz Reporter Jillian Andrews recently spoke with Dr. Michael Sider, a pediatrician at Yale New Haven Children’s Hospital, about safe sleeping…
Healthcare should take a fresh look at its thinking on conflicts of interest. It could be that those with the most conflicts useful things to…
Alison Bailey, MD, co-chair of the business of cardiology sessions at ACC.24, emphasized that reimbursement cuts can have a long-term negative impact on patient.
Results show a 0.94 correlation in mean deviation and statistical noninferiority to traditional methods for staging glaucoma.